Mjere ishoda u multiploj sklerozi

Ne postoji jedinstveno mjerilo za multiplu sklerozu (MS). Ovaj pojmovnik sadržava jednostavna objašnjenja za neke od naziva koji se koriste da bi se odredilo kako se multipla skleroza može mjeriti.

Pročitajte više o oblicima multiple skleroze Pročitajte više o povećanim očekivanjima za oboljele od PPMS-a Pročitajte više o ključnim spoznajama u vezi s multiplom sklerozom (MS) Pročitajte više o progresiji bolesti u multiploj sklerozi

^Referencije:

^{1. Multiple Sclerosis Coalition. The Use Of Disease – Modifying Therapies In Multiple Sclerosis: Principles and Current Evidence Summary. Dostupno na http://www.nationalmssociety.org/getmedia/1e64b96c-9e55-400e-9a64-0cdf5e2d60fe/summaryDMTpaper_-final. Accessed September 2016.}

^{2. Bermel, R. A. et al. The measurement and clinical relevance of brain atrophy in multiple sclerosis. The Lancet Neurology. 2006: 5(2): 158 – 170.}

^{3. Wiendl, H.; Meuth, S. G. Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis. Drugs. 2015: 75(9): 947-977.}

^{4. Giovannoni, G. et al. Brain Health: Time Matters in Multiple Sclerosis. 2015: pp 14.}

^{5. Lublin, F. D. et al. Defining the clinical course of multiple sclerosis. Neurology. 2014: 83(3): 278 – 86.}

^{6. National MS Society. Functional Systems Score (FSS) and Expanded Disability Status Scale. Available at http://www.nationalmssociety.org/For-Professionals/Researchers/Resources-for-Researchers/Clinical-Study-Measures/Functional-Systems-Scores-(FS-and-Expanded-Disab. Accessed September 2016.}

^{7. National MS Society. Magnetic Resonance Imaging (MRI). Dostupno na http://www.nationalmssociety.org/Symptoms-Diagnosis/DiagnosingTools/MRI. Accessed September 2016.}

^{8. National MS Society. Multiple Sclerosis Functional Composite (MSFC). Dostupno na http://www.nationalmssociety.org/For-Professionals/Researchers/Resources-for-Researchers/Clinical-Study-Measures/Multiple-Sclerosis-Functional-Composite-(MSFC). Accessed September 2016.}

^{9. MS Society UK. NEDA (no evidence of disease activity). Dostupno na https://www.mstrust.org.uk/a-z/neda-no-evidence-disease-activity. Accessed September 2016.}

^{10. National MS Society. 9-Hole Peg Test (9-HPT). Dostupno na http://www.nationalmssociety.org/For-Professionals/Researchers/Resources-forResearchers/Clinical-Study-Measures/9-Hole-Peg-Test-(9-HPT). Accessed September 2016.}

^{11. National MS Society. Paced Auditory Serial Addition Test (PASAT). Dostupno na http://www.nationalmssociety.org/For-Professionals/Researchers/Resources-for-Rarchers/Clinical-Study-Measures/Paced-Auditory-Serial-Addition-Test-(PASAT). Accessed September 2016.}

^{12. National MS Society. Managing Relapses. Dostupno na http://www.nationalmssociety.org/Treating-MS/Managing-Relapses. Accessed September 2016.}

^{13. National MS Society. Timed 25-Foot Walk (T25-FW). Dostupno na http://www.nationalmssociety.org/For-Professionals/Researchers/Resources-for-Researchers/Clinical-Study-Measures/Timed-25-Foot-Walk-(T25-FW). Accessed September 2016.}

^{14. Sethi, V. et al. Slowly eroding lesions in multiple sclerosis. Mult Scler. 2017 Mar; 23(3): 464‒472.}

^{M-HR-00001165}